Larimar Therapeutics

rare diseases
Research

FDA picks Denali, Neurogene and more for rare disease program

Four biotechs will get extra communication with agency officials in the FDA's "Operation Warp Speed" equivalent for rare disease.
Helen Floersh Jun 4, 2024 2:51pm
free bird maze fly freedom

Larimar's Friedreich's ataxia program free at last from FDA hold

May 21, 2024 9:55am
Italy parachute alps mountain paraglide

Stanford president resigns—Chutes & Ladders

Jul 21, 2023 9:30am
Traffic light go start restart green light

Larimar's limbo finally ends as FDA removes clinical hold

Sep 14, 2022 9:20am
FDA stop sign

Larimar still in limbo as company preps response to FDA hold

Aug 12, 2022 8:47am
FDA

Larimar in limbo as FDA maintains clinical hold

Feb 15, 2022 10:05am